Washington, Oct. 2 -- Congressman Nick Langworthy issued the following press release:
Washington, D.C. -October 2nd. Congressman Nick Langworthy today announced the introduction of the Biosimilars Access and Affordability Act, bipartisan legislation to expand access to lower-cost biosimilar prescription drugs and help bring them to market. The legislation updates Medicare policy to provide a clearer pathway for lower-cost biosimilar medicines that are actively moving toward the market, while protecting Medicare if those anticipated competitors never reach patients. Senator Marsha Blackburn (R-TN) is leading the companion bill in the U.S. Senate.
Biosimilars are highly similar versions of biologic medicines that can provide additional trea...